Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Savoldo

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
Blood|April 21, 2009
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor modelAntonio Di Stasi, Biagio De Angelis, Cliona M Rooney, et al.
Clinical Transplantation|November 15, 2006
Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infectionTimothy C Lee, John A Goss, Cliona M Rooney, et al.
Blood|September 18, 2009
Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)Biagio De Angelis, Gianpietro Dotti, Concetta Quintarelli, et al.
Blood|February 10, 2011
T cells redirected against CD70 for the immunotherapy of CD70-positive malignanciesDonald R Shaffer, Barbara Savoldo, Zhongzhen Yi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative diseaseBarbara Savoldo, Cliona M Rooney, Ruben E Quiros-Tejeira, et al.
Cellular Signalling|October 22, 2008
PPM1A and PPM1B act as IKKbeta phosphatases to terminate TNFalpha-induced IKKbeta-NF-kappaB activationWenjing Sun, Yang Yu, Gianpietro Dotti, et al.
Blood|July 20, 2007
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytesConcetta Quintarelli, Juan F Vera, Barbara Savoldo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2012
Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphomaSerena K Perna, Biagio De Angelis, Daria Pagliara, et al.
Science Advances|October 6, 2021
Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastomaEdikan A Ogunnaike, Alain Valdivia, Mostafa Yazdimamaghani, et al.
Molecular Cancer|November 20, 2009
Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regressionAaron E Foster, Fatma V Okur, Ettore Biagi, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
Blood|April 21, 2009
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor modelAntonio Di Stasi, Biagio De Angelis, Cliona M Rooney, et al.
Clinical Transplantation|November 15, 2006
Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infectionTimothy C Lee, John A Goss, Cliona M Rooney, et al.
Blood|September 18, 2009
Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)Biagio De Angelis, Gianpietro Dotti, Concetta Quintarelli, et al.
Blood|February 10, 2011
T cells redirected against CD70 for the immunotherapy of CD70-positive malignanciesDonald R Shaffer, Barbara Savoldo, Zhongzhen Yi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative diseaseBarbara Savoldo, Cliona M Rooney, Ruben E Quiros-Tejeira, et al.
Cellular Signalling|October 22, 2008
PPM1A and PPM1B act as IKKbeta phosphatases to terminate TNFalpha-induced IKKbeta-NF-kappaB activationWenjing Sun, Yang Yu, Gianpietro Dotti, et al.
Blood|July 20, 2007
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytesConcetta Quintarelli, Juan F Vera, Barbara Savoldo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2012
Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphomaSerena K Perna, Biagio De Angelis, Daria Pagliara, et al.
Science Advances|October 6, 2021
Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastomaEdikan A Ogunnaike, Alain Valdivia, Mostafa Yazdimamaghani, et al.
Molecular Cancer|November 20, 2009
Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regressionAaron E Foster, Fatma V Okur, Ettore Biagi, et al.
Pageof 16